Lawrence Van Helleputte

PhAc-ALGP-Dox, a Novel Anticancer Prodrug with Targeted Activation and Improved Therapeutic Index

P. Pokreisz, M. Pellens, P. Schöffski, 2022, Molecular cancer therapeutics.